ARS Pharmaceuticals, Inc. earnings per share and revenue

SPRY earnings per share for the last quarter are -0.20 USD whereas the estimation was -0.14 USD which accounts for -40.35% surprise. Company revenue for the same period amounts to 2.07 M USD despite the estimated figure of 575.00 k USD. Estimated earnings per share for the next quarter are -0.06 USD, and revenue is expected to reach 5.32 M USD. Also watch annual changes over time to get a bigger picture of SPRY earnings per share and revenue dynamics.